Our global businesses – generics, biosimilars, research services and novel biologics research – develop and manufacture innovative biopharmaceutical medicines for unmet medical needs and branded formulations cater to the Indian market. We truly believe drug innovation and therapy cost must interact effectively in a new financial matrix. Biocon’s business strategy of delivering affordable innovation is well aligned with this emerging paradigm. Biocon’s fully integrated business model spans the entire drug value chain, from pre-clinical discovery to clinical development and through to commercialisation.
CONTACT
Group Companies
Businesses
AHEAD OF THE CURVE
Path-breaking offerings.
Far-reaching impact.
Our reliable and easily integrated supply service ensures medicine continuity to our customers, patients, partners and healthcare systems globally.
Our reliable and easily integrated supply service ensures medicine continuity to our customers, patients, partners and healthcare systems globally.
PARTNERS
Partnering for life
Our symbiotic partnerships, leverage today’s scientific knowledge in its entirety and translate it into innovative medicines for patients.
PARTNERS
Partnering for life
Our symbiotic partnerships, leverage today’s scientific knowledge in its entirety and translate it into innovative medicines for patients.
